Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease

• Published in: Digestive diseases and sciences Vol. 68; no. 2; pp. 608 - 615
• Main Authors: Bodecker-Zingmark, L., Widbom, L., Hultdin, J., Eriksson, C., Karling, P.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.02.2023; Springer; Springer Nature B.V
• Subjects: Albumin; Albumins; Analysis; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Fungal; Antigens; Biochemistry; Biomarkers; Colitis; Colitis, Ulcerative - diagnosis; Crohn Disease - diagnosis; Crohns disease; Ferritin; Gastroenterology; Gastrointestinal diseases; Hepatology; Humans; Inflammatory bowel disease; Inflammatory Bowel Diseases - diagnosis; Lactoferrins; Leukocyte L1 Antigen Complex; Medicine; Medicine & Public Health; Oncology; Original; Original Article; Transplant Surgery; Viral antibodies; Inflammatory bowel disease; Calprotectin; Crohn's disease; ASCA; Ulcerative colitis

Background The pathogenic processes in the preclinical phase of inflammatory bowel disease (IBD) are mainly unknown. Aims To study typical antibodies for IBD in the preclinical phase in a cohort of Northern Sweden. Methods Antibodies typical for IBD (ASCA, pANCA, lactoferrin-ANCA, antibodies to gobl...